Table 2.
Medical therapy of pulmonary hypertension patients.
| IPH | PH due to BPD | P value | |
|---|---|---|---|
| N | 4 | 12 | |
| Home | 1 | 8 | .13∗ |
| Oxygen | |||
| (No. of patients) | |||
| Epoprostenol | 3 | 2 | .06∗ |
| (No. of patients) | |||
| Bosentan | 1 | 1 | .52∗ |
| (No. of patients) | |||
| Sildenafil | 3 | 11 | .45∗ |
| (No. of patients) | |||
| Months on | 17.5 (4–27.5) | 20 (12–29) | .99∗∗ |
| Therapy† |
*P value based on Fisher's exact test.
**P values based on Mann-Whitney U test.
†Data expressed as median (IQR).